+1 650 843 5250 ksantistevan@cooley.com
Kealan Santistevan focuses his practice on general corporate law. He represents startups, venture capital and private and public companies on a variety of issues.
Download full bio
Chicago-Based G2.com Reaches Unicorn Status With Series D Round
M1 Finance Closes $45 Million Series C
Orca Bio Raises $192 Million Series D to Transform Allogenic Cell Therapy
Forty Seven Agrees to Sell to Gilead for $4.9 Billion
TiVo and Xperi to Combine in $3 Billion All-Stock Merger
View all
Emerging Companies
Technology
Public Companies
Mergers & Acquisitions
Venture Capital
Trivia
Reading American History
Golden State Warriors
Hamilton
University of California, Los Angeles School of LawJD, 2016
University of California, BerkeleyBA, Double Major in Political Science and Media Studies2011
California
Chicago-Based G2.com Reaches Unicorn Status With Series D Round June 30, 2021
Orca Bio Raises $192 Million Series D to Transform Allogeneic Cell Therapy June 23, 2020
Forty Seven Agrees to Sell to Gilead for $4.9 Billion March 2, 2020
+1 650 843 5250 office ksantistevan@cooley.com
3175 Hanover StreetPalo Alto, CA 94304-1130